EURETINA 2020 Virtual Programme Information

EURETINA Sessions

To save session items, please click the heart icons. To view previously saved items, please click Load Favourites.


EURETINA Sessions Keynotes Symposia Instructional Courses All Days Fri 2nd Sat 3rd Sun 4th Load Favourites Programme Filter
timer Loading ... please wait
Thu 01
Chairperson(s):
R. Schlingemann THE NETHERLANDS,  G. Querques ITALY

Room:
Thu 01
Chairperson(s):
R. Tadayoni FRANCE

Room:
Thu 01
Chairperson(s):
X. Li CHINA,  R. Tadayoni FRANCE

Room:
Thu 01
Chairperson(s):
U. Schmidt-Erfurth AUSTRIA,  A. Loewenstein ISRAEL

Room:

Chairpersons: U. Schmidt-Erfurth AUSTRIA, A. Loewenstein ISRAEL

11.00
U. Schmidt-Erfurth AUSTRIA
Neovascular AMD: AI evidence on novel grounds

11.06
TBC
Diabetic retinopathy severity: Diagnostic and therapeutic guidance

11.12
TBC
Surgery of (pseudo) holes: Standards in macular surgery

11.18
TBC
Heads-up surgery: More options than ever

11.24
TBC
The myopia pandemic: The European response

11.30
Discussion

11.45
End of session

Thu 01
Chairperson(s):
A. Laidlaw UK,  J. Garcia-Arumi SPAIN

Room:

Chairpersons: A. Laidlaw UK, J. Garcia-Arumi SPAIN

12.00
TBC
Encirclement: what does it do? when to use it?

12.05
TBC
PVR, when how and what to peel

12.10
TBC
Retinectomy in PVR: early vs late

12.15
TBC
Risks with Tamponade agents

12.20
TBC
Realistic expectations in complex RRD

12.25
Discussion

12.45
End of session

Thu 01
Chairperson(s):
R. Schlingemann THE NETHERLANDS,  E. Midena ITALY

Room:

Chairpersons: R. Schlingemann THE NETHERLANDS, E. Midena ITALY

14.00
TBC
Retinopathy in Type 1 diabetic children

14.06
TBC
Retinal blood flow in diabetic retinopathy

14.12
TBC
Deferred laser in DME: follow ETDRS or aim for TelCaps?

14.18
TBC
Current and future DRCRnet protocols in diabetic retinopathy

14.24
TBC
Surgical solutions for DR, when to go in

14.30
Discussion

14.45
End of session

Thu 01
Chairperson(s):
S. Wolf SWITZERLAND,  N. Eter GERMANY

Room:

Chairpersons: S. Wolf SWITZERLAND, N. Eter GERMANY

15.00
TBC
Artificial Intelligence in OCT and fundus images: Overview

15.07
TBC
Artificial Intelligence for DR screening

15.11
TBC
From DRSS to new imaging and AI

15.15
TBC
Biomarker detection in OCT scans

15.19
TBC
Deep learning for assessment of AMD biomarkers

15.23
R. Schwartz UK
Using deep learning to detect reticular pseudodrusen on the UK Biobank – results and implications

15.27
Discussion

15.45
End of session

Thu 01
Chairperson(s):
K. Rezaei USA,  R. Tadayoni FRANCE

Room:

Chairpersons: K. Rezaei USA, R. Tadayoni FRANCE


TBC
Rescue the View


TBC
Lens Dislocation and Retinal Detachment in Marian Syndrome


TBC
Oops, no way to make sclerotomies


TBC
Limiting Phototoxicity During 3D Vitrectomy for Retinitis Pigmentosa


TBC
Air-Fluid Exchange…


TBC
Retinal Detachment with Suprachoroidal Hemorrhage


TBC
Subretinal Injection of Membrane Blu Dual


TBC
Submacular Perfluoron


TBC
Disposable Cryo


TBC
Perfluoron Guided Subretinal TPA


TBC
TBD

TBC
Discussion

TBC
End of session

Thu 01
Chairperson(s):
F. Holz GERMANY,  TBC

Room:

Chairpersons: F. Holz GERMANY, G. Staurenghi ITALY, A. Tufail UK

08.30
TBC
New insights from epidemiological studies

08.35
TBC
Managing AMD patients: impact of AI-based biomarker detection in OCT scans

08.40
R. Guymer AUSTRALIA
Approaches to slow progression of intermediate AMD

08.45
Discussion

08.52
J. Mones SPAIN
Novel therapeutic approaches for neovascular AMD – better efficacy/longer duration?

08.57
TBC
Long-acting drug delivery in nAMD: ARCHWAY phase 3 results

09.02
TBC
Improving adherence and outcomes in AMD therapy: Home monitoring

09.07
Discussion

09.15
End of session

Thu 01
Chairperson(s):
A. Loewenstein ISRAEL,  N. Eter GERMANY

Room:

Chairpersons: A. Loewenstein ISRAEL, N. Eter GERMANY

09.30
R. Schlingemann THE NETHERLANDS
New insights in the pathophysiology of diabetic macular edema in vein occlusion

09.36
P. Lanzetta ITALY
The management of macular edema in vein occlusion

09.42
J. Garcia-Arumi SPAIN
The surgical management of resistant cases of vein occlusion

09.48
TBC
Is OCT-A essential in vein occlusion?

09.54
U. Schmidt-Erfurth AUSTRIA
Artificial intelligence in vascular retinal disease

10.00
Discussion

10.15
End of session

Thu 01
Chairperson(s):
J. Garcia-Arumi SPAIN,  J. van Meurs THE NETHERLANDS

Room:

Chairpersons: J. Garcia-Arumi SPAIN, J. van Meurs THE NETHERLANDS

10.30
TBC
Viral retinitis

10.36
A. Adan SPAIN
New strategies with biologics in uveitis 

10.42
F. Pichi UNITED ARAB EMIRATES
OCTA in uveitis

10.48
TBC
Earlier antibiotic treatment is the most feasible step to improve treatment of endophthalmitis

10.54
TBC
Surgical treatment of endophthalmitis

11.00
Discussion

11.15
End of session

Thu 01
Chairperson(s):
C.C.W. Klaver THE NETHERLANDS,  R. Finger GERMANY

Room:

Chairpersons: C.C.W. Klaver THE NETHERLANDS, R. Finger GERMANY

13.45
TBC
Myopia prevention

13.50
TBC
AMD risk and progression

13.55
TBC
Glaucoma onset and progression

14.00
TBC
Diabetic eye diseases (DR & DME) onset, development of treatable stages, visual prognosis

14.05
TBC
Diet and eye disease

14.10
Discussion

14.30
End of session

Thu 01
Chairperson(s):
J.F. Kiilgaard DENMARK,  H. Heimann UK

Room:

Chairpersons: J.F. Kiilgaard DENMARK, H. Heimann UK

12.30
C. Maschi FRANCE
Diagnosis and treatment of peripheral exudative haemorrhagic chorioretinopathy

12.35
H. Annas THE NETHERLANDS
Retinal Hemeangiomas – new insights in genetics

12.39
TBC
PDT for choroidal haemangioma – long-term outcomes and treatment of recurrent exudative retinopathy

12.43
Discussion

12.50
TBC
Challenges in radiation induced macula oedema

12.54
H. Heimann UK
Photodynamic therapy of choroidal melanoma

12.58
E. Kilic THE NETHERLANDS
Molecular genetics and clinical implications in uveal melanoma

13.02
TBC
Treatment of Metastatic Uveal Melanoma

13.07
Discussion

13.15
End of session

Thu 01
Chairperson(s):
C.C.W. Klaver THE NETHERLANDS,  M. Zinkernagel SWITZERLAND, R. Schlingemann THE NETHERLANDS

Room:

Chairpersons: C. C.W. Klaver THE NETHERLANDS, M. Zinkernagel SWITZERLAND, R. Schlingemann THE NETHERLANDS

09.30
TBC
New insights in retinal disease derived from the EyeRisk study

09.37
TBC
Lessons learnt from single cell transcriptomics of the retina

09.44
TBC
Vascular-Glia-Neuron interactions in the retina

09.51
TBC
From screen to bedside: how to implement AI in the management of retinal disease?

09.58
Discussion

10.15
End of session

Keynote Lectures – EURETINA 2020 Virtual

Richard Spaide USA speakerfeature EURETINA Lecture Richard Spaide USA
Marta S. FigueroaKreissig LectureMarta S. FigueroaSPAIN
Stanislao RizzoGisbert Richard Lecture Stanislao RizzoITALY

Sign up to EURETINA


© EURETINA All rights reserved
Loading please wait